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Abstract 
There is considerable interest in the use of heavy atom nanoparticles as theranostic 
contrast agents due to their high radiation cross-section compared to soft tissue. However, 
published studies have primarily focused on applications of gold nanoparticles. This study 
applies Monte Carlo radiation transport modelling using Geant4 to evaluate the macro- 
and micro-scale radiation dose enhancement following X-ray irradiation with both imaging 
and therapeutic energies on nanoparticles consisting of stable elements heavier than 
silicon. An approach based on the Local Effect Model was also used to assess potential 
biological impacts. While macroscopic dose enhancement is well predicted by simple 
absorption cross-sections, nanoscale dose deposition has a much more complex 
dependency on atomic number, with local maxima around germanium (Z=32) and 
gadolinium (Z=64), driven by variations in secondary Auger electron spectra, which 
translate into significant variations in biological effectiveness. These differences may 
provide a valuable tool for predicting and elucidating fundamental mechanisms of these 
agents as they move towards clinical application.  
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Introduction 
Radiotherapy's primary objective is to selectively deliver high doses of radiation to tumours 
while sparing surrounding normal tissues. This has been driven in recent years by 
significant technical advances in radiation delivery, with advanced delivery techniques 
such as Intensity Modulated Radiotherapy (IMRT) and Volumetric Arc Therapy (VMAT) 
enabling highly conformal radiation delivery. These techniques are increasingly coupled 
with image guidance, currently using single and dual energy kV X-rays and with interest 
into expanding these techniques to incorporate Linac-MRI approaches in the future.   
Despite these advances, tumour dose escalation is often limited by the presence of nearby 
organs at risk, as inherent uncertainties in treatment delivery place strict limits on dose 
delivery to minimise radiotherapy-related side effects. As a result, there is a significant 
interest in techniques which to further improve dose specificity to tumour volumes. 
One approach to selectively spare healthy tissue is through the introduction of contrast 
agents – materials of high atomic number (Z) which strongly absorb ionising radiation. If 
these particles can be delivered preferentially to tumour volumes, they can selectively 
increase the target's absorption, offering both improved image contrast and selective 
increases in target dose. 
This approach has long been hampered by the lack of a suitable tumour-specific 
mechanism for delivering these contrast agents, but in recent years there has been 
significant interest in the application of high-Z nanoparticles for this purpose, following 
early work demonstrating the efficacy of gold nanoparticles as radiosensitising agents in 
mice 1. These nanoparticles were able to exploit the leaky tumour vasculature to achieve 
selective uptake in tumour volumes via the enhanced permeability and retention effect 
McMahon et al Optimising element choice for nanoparticle radiosensitisers 
 
4 
(EPR), and when combined with radiotherapy gave significant improvements in tumour 
control and overall survival in mice compared to radiotherapy alone. 
Following this early work, there have been several hundred publications investigating the 
radiosensitising properties of gold nanoparticles, studying the impact of factors such a 
particle size, shape, and surface coating 2. These investigations made use of both 
mathematical modelling of their interactions with incident ionising radiation 3–7 as well as 
numerous in vitro and in vivo experimental studies 8–11.  
Despite this, it remains an open question as to whether gold is the optimum material for 
this purpose. Only a handful of other elements have been investigated for use as 
radiosensitisers (including platinum, hafnium, gadolinium, and iron 12–16 ), and there have 
been no systematic experimental or theoretical comparisons between different materials. 
The focus on gold largely stems from the original rationale for the use of high-Z contrast 
agents. If sensitisation derives from increased absorption, then it is reasonable to seek to 
maximize the nanoparticles' atomic number, as X-ray mass energy absorption coefficients 
increase strongly with increasing atomic number (with the photoelectric effect scaling as 
Z3). Thus gold, being biocompatible and one of the heaviest stable elements, was a 
natural choice. 
While these assumptions are known to be valid for imaging applications, which are driven 
primarily by the attenuation and absorption coefficients of the contrast agent, experimental 
studies of gold nanoparticle radiosensitisers have challenged this view for therapy. In this 
context, it is important to distinguish between dose enhancement – that is, the increase in 
energy deposited in the target volume due to the presence of the nanoparticles – and 
radiosensitisation, the increase in the biological effects of radiation observed when used in 
McMahon et al Optimising element choice for nanoparticle radiosensitisers 
 
5 
combination with nanoparticles. Although it was originally expected that these effects 
should be closely related for high-Z contrast agents, experimental investigations have 
shown that the radiosensitising effects of gold nanoparticles are very poorly correlated with 
macroscopic dosimetric calculations (2), with little or no relationship apparent between 
calculated dose enhancement and observed biological effects. In particular, 
radiosensitisation is often seen to be significantly greater than the increase in physical 
dose, and effects are seen using clinical megavoltage X-ray sources where the addition of 
nanoparticles leads to only negligible increases in the macroscopic dose. These results 
indicate that macroscopic dose enhancement alone is not a useful predictor of 
radiosensitisation across different cell lines and nanoparticle preparations. 
As a result, several new hypotheses have been advanced to attempt to understand and 
predict these biological effects. One key observation from modelling of nanoparticle-
radiation interactions is that, on the micro- and nano-scale, the dose distribution around 
gold nanoparticles is highly heterogeneous. Extremely high doses are deposited in the 
immediate vicinity of the nanoparticle, driven by the large number of low-energy secondary 
Auger electrons produced following ionisation in high-Z elements 17–19. Similar 
heterogeneous dose distributions are seen in ion-based radiotherapy, where techniques 
such as the Local Effect Model (LEM) have been developed to explain their superior 
biological effectiveness compared to relatively uniform X-ray exposures20,21 Analysis of 
nanoparticle-enhanced therapy based on these techniques have shown a similar increase 
in biological impact, potentially explaining some of the observed sensitisation in gold 
nanoparticle enhanced radiothearpy 22–24. 
If nanoscale dose deposition is an important factor in the radiosensitising impact of 
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nanoparticle contrast agents, then it is no longer clear that the heaviest elements are the 
best choice, as these nanoscale effects are poorly characterised by macroscopic dose, 
and care must be taken to incorporate the particles' potentially different impacts when 
exposed to X-ray imaging and therapeutic energies. 
This work presents the first systematic computational study of the impact of elemental 
composition on nanoparticle-radiation interactions for kilovoltage and megavoltage X-ray 
exposures, spanning elements from silicon (Z=14) to mercury (Z=80). While some of these 
elements may not be suitable for use as nanoparticle contrast agents, the full range of 
elements in this range was investigated to fully explore the underlying mechanisms of 
dose deposition. 
These interactions are investigated in terms of total dose deposition, nanoscale dose 
distribution, and biological effects assessed through an approach based on the Local 
Effect Model. Complete reference data sets for these particles are also made available in 
the Supporting Information. 
Methods 
Analytic macroscopic dose enhancement calculations 
To provide a reference against which to compare the nanoscale calculations, macroscopic 
dose enhancement factors were calculated for all elements. Based on the assumption that 
nanoparticle contrast agents can be considered as homogeneously distributed throughout 
a target volume, potential dose enhancement per unit mass of contrast agent can be 
approximated simply as the ratio of the mass energy absorption ratios,  
tissue
Z
μ
μ
=ZDER . 
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This can then be scaled by the particle concentration to give an actual dose enhancement 
value.  These values were calculated for all materials as a function of radiation energy 
based on values from NIST 25.  
For ease of comparison between different materials, a normalised ratio has been 
calculated at each energy, normalising each material's dose enhancement ratio to the 
maximum contrast possible at that energy. This offers an easier comparison between 
different materials, as the maximum achievable dose enhancement varies greatly as a 
function of energy. 
Monte Carlo nanoparticle dose deposition calculations 
Radiation-nanoparticle interactions and resulting radial dose distributions were modelled 
using Geant4.9.6 (patch 3) 26, simulating individual 20 nm diameter nanoparticles placed 
within the centre of a 10 μm a side cube of water. Livermore low-energy physics models 
were used for radiation transport within the nanoparticle volume, with Geant4-DNA models 
used in the surrounding water volume 27. The use of water as a detector volume for the 
dose distribution is necessarily an approximation to biological systems which contain a 
wider range of different chemical species, but is a necessary simplification due to the 
current lack of appropriately detailed models of low-energy radiation interactions with 
organic systems. 
Nanoparticles were modelled as pure spheres of individual elements ranging from Z=14 to 
Z=80, with material properties (isotope distribution, density, etc) taken as Geant4 defaults 
for STP, based on the NIST reference values. Elements which were liquid or gaseous 
under these conditions were not considered for plotting or further analysis. 
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Initially, interactions were modelled using monochromatic keV X-rays. As ionisation cross-
sections and Auger spectrum depend strongly on photon energy for keV X-rays, individual 
X-ray energies were used for each material. Energies were set to 20 keV above the K-
edge of the material being exposed (ranging from 22 to 102 keV). This enables 
comparisons to be made between all elements following similar ionising events, which 
primarily occur in inner shells to allow for the full impact of Auger electrons to be 
investigated. Total primary particles simulated ranged from 8×108 to 1.6×109 photons, 
depending on nanoparticle and beam energy, delivered as a 20 nm diameter beam 
exposing the whole particle. 
Clinically-relevant Megavoltage exposures were modelled using both the photon and 
electron components of a 6 MV Linac spectrum at the 80% Percentage Dose Depth (PDD, 
the depth at which the dose deposited by the field has fallen to 80% of the peak dose), 
obtained through Monte Carlo simulation as described previously 23,28. In these 
simulations, 3×108 primary photons sampled from a published 6 MV Linac spectrum 29 
were directed in a 10 cm diameter beam along the axis of a cylindrical block of water of 20 
cm length and diameter. These simulations scored dose along the beam direction as well 
as the spectrum of both photons and electrons at the 80% dose-depth position, 8.7 cm 
below the surface. To model nanoparticle irradiations, these spectra were scaled down to 
nanometre scales and used to expose individual GNPs, as was the case for kilovoltage 
photons. Once again, radial doses and secondary particle distributions were calculated for 
nanoparticles with atomic numbers ranging from 14 to 80. These simulations modelled 
1.6×109 photons, and approximately 2.5×107 electrons, based on the input phase space, 
scaled to a 20 nm diameter beam. 
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For both types of exposure, all secondary particles emitted from the nanoparticles were 
scored, identifying the process which led to their emission, as well as the dose deposited 
in concentric 2 nm shells around the nanoparticle, out to a range of 1 μm from the 
nanoparticle.  
For each nanoparticle/radiation combination studied in this work, the full secondary 
particle distributions as well as the radial dose distributions (broken down by contributing 
process) are provided in the Supplementary Information to support further investigation. 
Nanoscale Radiosensitisation Calculations 
An approach based on the Local Effect Model (LEM-1) was used to evaluate the potential 
biological impact of these nanoscale dose depositions. The LEM was developed to 
describe the biological effectiveness of highly charged ions 20,21, which have a significantly 
higher biological effectiveness than a similar dose of X-rays. This technique, as well as its 
application to nanoparticle-enhanced therapy, has been described in detail elsewhere 21,22, 
and is reviewed below for completeness. 
The LEM suggests that the biological effectiveness of heterogeneous exposures can be 
understood in terms of the dose at each point within the cell, rather than the average dose 
to the cell. Specifically, it postulates that cells die to the formation of 'lethal lesions', with 
survival given by   Ne=NS  , where N is the number of lesions formed in the cell. N can 
be expressed as    S{D}=DN ln , where S(D) is the survival of cells following exposure to 
a uniform dose D of X-rays. 
For heterogeneous exposures, the LEM assumes that a) the microscopic lesion density at  
given dose is the same as that across the whole cell; and b) the total number of lesions 
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within the cell is dependent on the integral of the probability of a lesion forming at each 
point. Thus, the total number of lesions is given by  
V
dV
DN=N rtot  , where rD  is the 
dose delivered to the point r, exposing a fraction of the total cell volume given by 
V
dV
. As 
a result of non-linear terms in the dose response function, the localised doses of highly 
charged ion therapies drive significantly more cell killing than a uniform exposure to the 
same average dose of X-rays. 
These concepts can also be applied to nanoparticle-enhanced therapies, and have 
successfully demonstrated more accurate prediction of radiation sensitization in 
nanoparticle enhanced therapies, suggesting these effects may play an important role in 
nanoparticle sensitization (22, 23).  
In this work, the number of lesions induced per nanoparticle-radiation interaction, NPN , 
was calculated by summing the damage as a function of distance from the nanoparticle, 
assuming the linear-quadratic model of response to uniform exposures,  
2βDαDe=NS  . 
This gives a total number of lesions as      VdVrβD+rαD=N NPNPNP /2 , where Dnp(r) is 
the radial dose distribution around a nanoparticle following an ionising event (as illustrated 
in Figure 4). For ease of comparison, the potential cell killing impact of a single 
nanoparticle-radiation interaction was equated to a uniform X-ray dose 
EffD , defined as 
2
EffEffNP βD+αD=N . It should be noted that this approach implicitly assumes that no two 
nanoparticle-radiation interactions occur close enough together to significantly overlap, but 
this is generally true for doses typically used in therapy as the number of nanoparticle 
ionisations per cell is typically small (<10). 
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For the purposes of this analysis, the calculated radial dose distribution is smoothed using 
a spherically symmetric Gaussian kernel, as in ion therapy approaches (20), with σ=10 
nm. This represents the diffusion of potentially damaging biological and chemical species 
following initial radiation interactions while preserving the total energy deposited in the 
system. This has several effects, including a reduction in sensitivity to statistical 
uncertainties and the removal of non-physical dose peaks at extremely small radial 
positions.  
Finally, these effects are converted into a Relative Biological Effectiveness (RBE). The 
RBE is defined as 
NP
X
D
D
=RBE  where Dx is the reference X-ray dose, chosen to be 2 Gy in 
this work, and DNP is the dose which yields equal survival in the presence of nanoparticles. 
The number of lethal lesions (and thus survival) was calculated for a given condition 
according to 
npXtot ηN+N=N , where XN  is the number of lesions induced by the uniform 
X-ray dose, NPN is the number of lesions induced per nanoparticle-radiation interaction, 
and η  is the number of nanoparticle-radiation interactions in a given exposure. This is 
calculated as the product of the delivered dose, the number of interactions per 
nanoparticle per Gray for the particle/radiation type under consideration (taken from 
ionisation cross-sections for monoenergetic keV exposures, and the phase space 
calculations for linac exposures) and the number of particles present in the volume, taken 
to be 500 μg/mL in this work. 
It is important to note that this analysis assumes that all of the volume around the 
nanoparticle is uniformly sensitive to ionising radiation. This is equivalent to the 
assumption that nanoparticles are distributed uniformly throughout both the nucleus and 
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cytoplasm of the cell. While this may not accurately describe all particles (e.g. 
nanoparticles excluded from the nucleus may be far from DNA and other sensitive targets, 
reducing the biological impact of low energy electrons), it is a useful initial guide to 
biological sensitisation. The data presented in the Supplementary Information provides a 
foundation for further analysis of these distribution-related effects. 
Results 
Macroscopic analysis 
Figure 1 illustrates the mass energy absorption coefficient for soft tissue and a series of 
high-Z materials (Gold, Hafnium, Gadolinium and Iodine) which are of interest as contrast 
agents, along with their ratio which is a guide to macroscopic dose enhancement. 
Although there is a general trend for higher Z atoms to see greater absorption at keV 
energies, this is not universally true. Due to the sudden large increases in absorption 
coefficient seen when photons have energies just above those required to eject an 
electron from an inner shell (particularly from the K and L shells in these elements, known 
as ‘absorption edges’), there are sharp discontinuities in these distributions which can 
often lead to lighter elements seeing stronger absorption. Thus even in the relatively 
simple macroscopic case, optimum contrast is not necessarily delivered by the material 
with the greatest atomic number. 
This is further illustrated in Figure 2, which maps the relative potential dose enhancement 
per unit mass of contrast agent for monochromatic X-ray exposures. At low energies, 
these effects are dominated by bands representing elements which are strongly absorbing 
due to M, L, or K edge effects (respectively, from low to high energy). However, it can be 
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seen that these bands are quite broad, with large numbers of elements within 25% of the 
maximum dose enhancement at a wide range of energies.  
Higher energies see significantly less material dependence, as these effects are 
dominated by Compton interactions which are largely independent of atomic number, with 
all elements offering within 20% of the maximum contrast in the Compton dominated 
region from 1 to 5 MeV.  
Notably, it can also be seen that all element with Z>=60 are within approximately a factor 
of 2 of the maximum achievable macroscopic contrast at all energies >= 10 keV. This 
suggests that even in imaging applications there is value in further investigating materials 
in this range, as the small increase in concentration needed to drive macroscopic effects 
may be offset by the greater flexibility offered by a wider range of candidate materials for 
nanoparticle design. 
Contributing processes on the macro- and nano-scale. 
A breakdown of the processes contributing to both total and local (< 1 μm) dose deposition 
is shown in Figure 3, for 20 nm diameter nanoparticles exposed to either tuned kilovoltage 
irradiation (left) or a 6 MV Linac spectrum at the 80% PDD (right). For kilovoltage 
interactions, the total energy deposition is dominated by photoelectrons and fluorescence 
photons at low and high energies respectively, with a small contribution of Auger electrons 
and Compton scatter. However, considering only dose deposited within 1 μm of the 
nanoparticle, Auger electrons are the primary source of energy deposition for all elements, 
as photoelectrons and fluorescence photons have too long a range to deposit significant 
dose in the vicinity of the nanoparticle.  Notably, unlike other processes Auger energy 
distribution has a multi-peaked behaviour on this scale, driven by the variation in Auger 
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electron yield, energy and range as a function of atomic number. 
In megavoltage exposures, total energy deposits are dominated by Compton scatter and 
there is now a significant contribution from secondary electrons generated by the beam 
interacting with the surrounding water volume, although the contributions of photoelectrons 
and fluorescence does increase for the heaviest elements. The distribution is again 
noticeably different on the local scale, where electron impact remains a dominant 
contribution but the effects of Compton electrons are mitigated due to their long range and 
a larger contribution of Auger electrons is seen, although still on a smaller scale than in 
kilovoltage exposures. Significantly, the total short-range energy deposit per interaction is 
roughly constant for MV exposures, as a result of electron scattering's weak dependence 
on atomic number.  
Nanoscale energy and dose distributions 
Figure 4 presents the nanoscale radial energy and dose distributions for an average 
ionising event (that is, a radiation-nanoparticle interaction which produces at least one 
secondary particle) in nanoparticles of a selection of elements, under the same conditions 
as in Figure 3.  
As expected from Figure 3, there is considerable variability among the different elements, 
driven by variations in Auger spectra. Differing Auger electron distributions can drive very 
high depositions in the immediate vicinity of the nanoparticle, broad peaks at moderate 
ranges (several hundred nm) or mixtures of these effects. These variations mean that it is 
challenging to predict which material delivers the highest dose enhancement at different 
distances from the particle, or which may offer the greatest radiosensitisation in general. 
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By contrast, megavoltage irradiations see only small variation with material. Again, this is 
in line with Figure 3, as the primary mechanisms of interaction (Compton and electron 
scattering) have very little dependence on atomic number for either cross-section or 
secondary electron spectra, giving broadly similar responses for all elements. 
Because of the localised nature of interactions with these nanoparticles, for both cases 
these energy distributions correspond to very high local doses in the immediate vicinity of 
the nanoparticle, with kV exposures again showing significantly more variation than MV 
exposures.  
Biological Impacts 
An approach based on the Local Effect Model (LEM) was used to assess the potential 
biological impact of these dose distributions, as presented in Figure 5.  A complex material 
dependency is once again seen for kilovoltage exposures, with two distinct local maxima 
seen in the rates of damage predicted by the LEM, centred approximately around Z=34 
and Z=68. Elements in these energy ranges have their primary Auger electrons (from K 
and L shell, respectively) with energies around 9 to 10 keV, with numerous additional 
lower-energy electrons with energies around 2 keV and below, corresponding to ranges in 
water on the order of 1 μm and 100 nm, respectively.  
Material has a limited impact on MV Linac exposures – while there is a slight variation due 
to Auger electron contributions around Z=34 and 68, these are small, compared to the 
largely constant background independent of atomic number, driven by similar absorption 
of secondary electrons from the MV spectrum. 
A small number of elements, including Europium, Gadolinium and Ytterbium, seem to lie 
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significantly above the overall trend. A comparison of their physical properties suggests 
the common feature driving this effect is a relatively low density. This reduces self-
absorption of secondary electrons, which can substantially increase the dose deposited in 
the vicinity of the nanoparticles. 
Relative Biological Effectiveness (RBE) for nanoparticle-enhanced treatments in these 
conditions is presented in Figure 6, calculated for cells exposed to 500 μg/mL of uniformly 
dispersed 20 nm diameter nanoparticles exposed to a dose of 2 Gy. The trends with 
atomic number largely mirror those in Figure 5, with significant variation seen in keV 
energies but relatively limited variation for MV Linac exposures. RBE calculations also 
introduce a dependency on the relative ionisation cross-section, however, which acts to 
significantly reduce the impact of low-Z agents at keV energies, and all materials at MeV 
energies.  
Discussion 
Studies of nanoparticle contrast agents and sensitisers have focused on very high-Z 
agents. While this follows naturally from the macroscopic dose calculations, an increasing 
body of evidence suggests this is a poor guide for biological radiosensitisation. Expanding 
this field to encompass other nanoparticle compositions may not only enable better tuning 
of nanoparticle dose distributions, but also the development of novel nanoparticle designs 
exploiting other element's physical, chemical or biological properties.   
In this study we report on significant variations in predicted radiosensitisation between 
different elements which are not well described by macroscopic dose enhancement. 
These effects are driven by differences in Auger electron spectra, which depend primarily 
on the irradiated element. The contribution of Auger electrons at short range initially rises 
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due to increasing energy deposited by K-shell Auger electrons before falling as their 
energies become too great to deposit significant local energy and their yield falls due to 
competition from fluorescence. However, at higher atomic numbers L- and M-shell 
electrons become sufficiently energetic to contribute to radiosensitisation, leading to a 
peak around Z=68. Finally, at the upper limit of this study L-shell Auger electron energies 
also become too great and their local contribution begins to reduce. Alongside these 
trends is a variation in the range over which energy is primarily deposited, as can be seen 
in Figure 4. This may be an important factor in determining sensitising properties if 
nanoparticles are not uniformly distributed, as has been assumed in this analysis.  
Interestingly, for a clinical megavoltage source, Auger electrons are significantly less 
important across all elements, as interactions are dominated by Compton and electron 
scattering events, which are primarily outer-shell interactions. This leads to a relatively 
material-independent prediction for sensitisation at megavoltage energies, and 
significantly lower overall effect. 
This observation may prove very important for the usage of particles in a theranostic 
context, where imaging and therapeutic functions are combined. The very different 
interactions at high and low energies may present challenges in these applications, such 
as greater than expected sensitisation in normal tissues to pre-treatment imaging 
delivered by CT in a contrast-enhanced setting. As a result, care must be taken to 
evaluate the interactions of these particles with all aspects of the treatment pathway.   
These results also present an avenue for validating models of the biological impacts of 
nanoparticle radiosensitisers. As the nanoscale dose model suggests a specific, complex 
dependence of radiosensitisation on nanoparticle material, comparing the radiosensitising 
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properties of nanoparticles composed of different materials in biological systems offers a 
sensitive probe of the validity of these assumptions, in comparison to other possible 
radiosensitising mechanisms such as biological or chemical stresses induced by the 
nanoparticles which would be expected to have a different material dependence. Such 
approaches of course depend on the development of nanoparticles with different 
compositions but similar biological uptake and localisation. 
If validated, this wider range of material choices suggested by this analysis may open 
novel options for new nanoparticle designs which may make use of a range of elements in 
their design. This has the potential to offer more affordable therapeutic options, as well as 
new methods for optimisation of sensitisation, taking advantage of the chemical or 
biological properties of materials which may initially have been rejected as poor 
candidates for radiosensitisation due to their low atomic number. As noted above, this is 
also potentially significant for the development of theranostic nanoparticles, whether 
directly through improved X-ray absorption within the target, or by selecting elements 
which are useful for alternative imaging techniques, such as MRI.  
One other observation in these results is the contribution of particle density to 
sensitisation. The least dense elements produce dose distributions which are predicted to 
lead to significantly greater sensitisation than would be expected based on atomic number 
alone, which is believed to be driven by low-energy secondary electrons having an 
increased probability of escape. This suggests that less dense particle preparations (e.g. 
combining some atoms of a high-Z material in a crystal or organic molecule with lighter 
elements) may drive superior radiosensitisation than a similar mass of material contained 
in denser pure nanoparticles (subject to the ability to deliver a sufficient total concentration 
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of contrast agent). Such an approach has been taken in development of hafnium-oxide 
and gadolinium-based nanoparticles, which have reported significant radiosensitising 
properties (13, 14) and are moving towards clinical trials. 
It is important to note that this is a preliminary exploration of the impact of material choice 
in nanoparticle radiosensitisation, only considering spherical pure elemental nanoparticles 
of one size and limited energy selections to illustrate underlying mechanisms. Actual 
exposure conditions in a particular study will lead to significant differences in these 
spectra. For example, different irradiation energies will lead to significant changes in 
interaction cross-sections. Similarly, nanoparticle size and shape can have a significant 
impact on the low-energy portion of the secondary spectra, as small nanoparticles will see 
significantly less internal absorption, and other nanoparticle shapes (e.g. nanorods) will 
have a greater surface : volume ratio, meaning electrons will have to traverse less high-Z 
material before escaping the nanoparticle. The exactly impact of nanoparticle size and 
shape depends strongly on the particle composition and incident X-ray energy, but is likely 
to be of the same order of magnitude as that seen due to density effects in Figure 5 noted 
above (i.e. 10-50% change in damage, depending on energy and particle size). These 
effects will be driven by very low energy electrons, and as such will depend strongly on the 
nanoparticle distribution. Significant material-specific tuning is also likely to be possible, 
combining particular characteristics of elements with optimised sizes and shapes. 
While the current analysis is sufficient to demonstrate that there is a viable physical 
rationale not to focus exclusively on the heaviest elements when developing 
radiosensitising nanoparticles, there are also other reasons to explore alternative 
compositions. In addition to the physical effects discussed in this work, there is evidence 
McMahon et al Optimising element choice for nanoparticle radiosensitisers 
 
20 
that some or all of the sensitisation seen when some metal nanoparticles are combined 
with ionising radiation are not due directly to nanoparticle-radiation interactions increasing 
the dose in the cell, but alternative pathways such as oxidative stress (either induced by 
the nanoparticles alone30,31 or nanoparticle enhancement of hydroxyl radical (OH) yield 
following radiation exposure32,33), mitochondrial disruption34,35, or inherent cytotoxicity of 
the nanoparticles36. While these effects are in many cases even less well understood than 
effects that depend on physical dose, it is clear that they also depend on nanoparticle 
composition and coating. As a result, it is clear that development of an optimal particle for 
radiosensitisation will involve a complex balancing of physical, chemical and biological 
properties of its constituent materials.  
Conclusions 
In conclusion, these results present a much more complex picture of the radiosensitising 
properties of heavy atom nanoparticles than would be expected from their mass energy 
absorption coefficients alone. This suggests that there is considerable merit in 
investigating nanoparticle preparations which make use of other light elements, to 
potentially optimize the radiation-related sensitising effect and to make best use of the 
wide range of chemical and biological properties which would be accessible through novel 
nanoparticle designs. 
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Figures 
 
Figure 1: Comparison of Mass Energy Absorption coefficients for soft tissue and a range 
of heavy elements (top). Although higher-Z metals generally have the highest absorption 
coefficient, this is not always the case, with edge structure introducing significant variation. 
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This is similarly apparent in the ratio of metal absorption to that of soft tissue (bottom), 
which shows gold’s absorption is surpassed by other metals over a wide range of the 
kilovoltage region. 
 
Figure 2: Normalised enhancement per unit mass for a range of materials and energies. 
At each energy, the enhancement ratio has been normalised to that of the maximum at 
that energy. Clear structure can be seen at low energies, with bands corresponding to K-, 
L- and M-shell absorption. At higher energies, little variation in potential enhancement is 
seen as absorption is dominated by Compton interactions. 
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Figure 3: Top: Total energy emitted from a nanoparticle by various processes following an 
ionising event as a function of atomic number, for tuned keV irradiation (left) or 6 MV Linac 
exposure (right). At keV energies, photoelectrons and fluorescence dominate these 
effects, while for MV energies ionisations by secondary electrons in the beam spectrum 
dominate. Bottom: Distribution of energy deposited within 1 micron of a nanoparticle 
centre per ionising event, broken down according to contributions of various processes. At 
keV energies, the majority of energy is deposited by Auger electrons, which have a 
complex energy dependence, while for MV interactions electron impact remains the 
dominant contribution. 
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Figure 4: Nanoscale radial energy distributions (top) and dose distributions (bottom) 
around 20 nm nanoparticles of various metals following a single ionising event caused by 
either tuned keV X- rays (left) or a 6 MV Linac spectrum (right). Significant complexity is 
seen in keV irradiations, with differing energy distributions depending on the characteristic 
Auger cascade produced by the material. By contrast, MV irradiation produces similar 
energy distributions in all cases, as Auger electrons play a reduced role. Bottom: For both 
spectra, there remain high localised doses in the vicinity of high-Z nanoparticles. 
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Figure 5: Biological effects of nanoparticle-radiation interactions, in terms of effective dose 
deposited by a single ionising event, for cells with α/β ratios of either 3 (blue) or 10 (green) 
for keV (left) and MV (right) exposures. For keV irradiation, significant variation is seen, 
with several distinct peaks of effect, reflecting nanoscale Auger dose distributions. By 
contrast, MV interactions are relatively slowly-varying over the entire range of atomic 
number. 
Figure 6: Relative Biological Effectiveness (RBE) predicted by the LEM for addition of 
nanoparticles to cells at concentrations of 500 μg/mL for 2 Gy exposures using kilovoltage 
(left) and megavoltage (right) exposures. These trends largely follow those seen in in the 
per-interaction rates in Figure 5, but there is also a significant contribution from the 
interaction cross-section of the radiation, reducing the impact of the lightest elements at 
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keV energies, and all elements at MeV energies. 
 
